Natural correction of hyperuricemia, not by allopurinol, could slow down the progression of renal disease in the patient with chronic kidney disease stage 3
Correction of hyperuricemia can slow down the progression of renal disease in animal study. However, there is limited data regarding the effect of lowering serum uric acid in patients with hyperuricemic chronic kidney disease (CKD) stage 3 (estimated GFR [eGFR] 30-60 mL/min). Methods: We retrospecti...
Saved in:
Main Authors: | Kyung Sun Park (Author), Jai Won Chang (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of allopurinol on the progression of chronic kidney disease
by: Aygul Ozdemir, et al.
Published: (2017) -
Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease
by: Su Hyun Song, et al.
Published: (2021) -
Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study
by: Youssef Saeed Alghamdi, et al.
Published: (2020) -
Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
by: Sollip Kim, et al.
Published: (2017) -
The effect of allopurinol on renal outcomes in patients with diabetic kidney disease: A systematic review and meta-analysis
by: Binbin Wu, et al.
Published: (2022)